Print this Page
Cancer Biology Members
Additional Topics in This Section
The ultimate goal of the program is identify suitable targets for intervention in cancer and use this information to inform novel preclinical studies and clinical trials that target cooperating cancer-promoting pathways. In order to make this possible, the Cancer Biology program works closely with members of the Developmental Therapeutics and Fox Chase's Institute for Personalized Medicine.
Program Leaders
Primary Members
- Andy Andrews, PhD
- Alfonso Bellacosa, MD, PhD
- Jeff Boyd, PhD
- Kathy Q. Cai, MD, PhD
- Paul Cairns, PhD
- Xiaowei Chen, PhD
- Edna Cukierman, PhD
- Greg H Enders, MD, PhD
- Gary R Hudes, MD
- Richard A Katz, PhD
- Andres J.P. Klein-Szanto, MD, PhD
- Alfred G Knudson Jr, MD, PhD
- Vladimir M Kolenko, MD, PhD
- Warren D. Kruger, PhD
- Alexander Kutikov, MD
- Alla Lapidus, PhD
- Joan Lewis-Wambi, PhD
- Biao Luo, PhD
- Beatrice Mintz, PhD
- Alana O'Reilly, PhD
- Jeffrey R Peterson, PhD
- Fabrice Roegiers, PhD
- Alexei Tulin, PhD
- Robert G Uzzo, MD, FACS
- Hong Yan, PhD
- Zeng-jie Yang, MD, PhD
- Tim J Yen, PhD
